AU022751 Activators

Bisphenol A can bind to estrogen receptors, which may lead to the activation of signaling pathways such as PI3K/Akt or MAPK/ERK. In cells where EZH inhibitory protein is responsive to these pathways, the downstream effect of Bisphenol A binding to estrogen receptors could lead to the activation of EZH inhibitory protein through post-translational modifications.

Trichostatin A is a histone deacetylase inhibitor that can increase acetylation of histones, leading to an open chromatin structure and facilitating transcription factor access. This can activate EZH inhibitory protein by allowing transcription factors that promote its activation to gain access to its regulatory regions on the DNA.

5-Azacytidine is a DNA methyltransferase inhibitor that reduces DNA methylation, which could potentially lead to the activation of EZH inhibitory protein by enabling the expression of genes that contribute to its activation or by directly affecting the methylation status of the regulatory regions of the EZH inhibitory protein itself.

SAHA, also known as Vorinostat, is another histone deacetylase inhibitor that increases histone acetylation, promoting an open chromatin state. This can enhance the transcription of genes that are responsible for the activation of EZH inhibitory protein, leading to its functional activation.

Retinoic Acid can activate retinoic acid receptors (RARs) which can regulate gene expression. Activation of RARs could lead to the activation of genes that encode proteins that directly interact with and activate EZH inhibitory protein.

Genistein is a tyrosine kinase inhibitor that can also modulate the activity of certain transcription factors. It may activate EZH inhibitory protein through inhibition of tyrosine kinases that could be repressive to its activation state or by facilitating the activity of transcription factors that promote its activation.

Sodium Butyrate, a short-chain fatty acid, acts as a histone deacetylase inhibitor. It can lead to increased acetylation of histones around the regulatory regions of EZH inhibitory protein, thus promoting its activation by enhancing the transcription of genes that participate in its activation.

Resveratrol can activate sirtuin pathways, which are involved in deacetylation processes. Sirtuin activation could lead to activation of EZH inhibitory protein by promoting the deacetylation of repressive marks on histones near the protein's regulatory elements, thereby fostering an environment conducive to its activation.

Curcumin is known to inhibit NF-κB signaling, a pathway that can be involved in the repression of certain genes. Inhibition of this pathway can lead to the activation of EZH inhibitory protein by preventing the NF-κB-mediated repression of factors that are necessary for its activation.

Spermidine can induce autophagy and influence epigenetic modulation. Through the promotion of autophagy, spermidine could facilitate the degradation of proteins that negatively regulate EZH inhibitory protein, thus leading to its activation.